Drug
VA
VA is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
2
50%
Ph phase_2
1
25%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 32 (50.0%)
N/A1 (25.0%)
Trials by Status
completed250%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_2
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
NCT06532552
recruitingphase_3
HVA vs IA/DA or VA in the Treatment of ND HR-AML
NCT06810791
completedphase_3
To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
NCT05331014
completednot_applicable
Effect of Trans Fatty Acids From Ruminant Sources on Risk Factors for Cardiovascular Disease
NCT00942656
Clinical Trials (4)
Showing 4 of 4 trials
NCT06532552Phase 2
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
NCT06810791Phase 3
HVA vs IA/DA or VA in the Treatment of ND HR-AML
NCT05331014Phase 3
To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
NCT00942656Not Applicable
Effect of Trans Fatty Acids From Ruminant Sources on Risk Factors for Cardiovascular Disease
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4